Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation confers functional neuroprotection in global ischemia

Neurotoxicity Research

Volumn 19, Issue 3, 2011, Pages 462-471

  Fatehi Hassanabad, Zahra ^a   Tasker, R A ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Excitotoxicity; Infarct; Neurobehaviour; Nitric oxide; Stroke

Indexed keywords

GLUTAMIC ACID; HYDROGEN PEROXIDE; NITRITE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN HOMOGENATE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CEREBROSPINAL FLUID; COMMON CAROTID ARTERY; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; MORTALITY; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; ROTAROD TEST; TISSUE INJURY;

ANIMALS; DISEASE MODELS, ANIMAL; HYDROGEN PEROXIDE; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PPAR GAMMA; THIAZOLIDINEDIONES;

MUS; RODENTIA;

EID: 79951944520     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-010-9201-3     Document Type: Article

References (71)

1. A Aljada L O'Connor Y-Y Fu SA Mousa 2008 PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis Angiogenesis 11 361 367 1:CAS:528:DC%2BD1MXivFCgsg%3D%3D 10.1007/s10456-008- 9118-0 18810647
2. M Allahtavakoli R Moloudi MK Arababadi A Shamsizadeh K Javanmardi 2009 Delayed post ischemic treatment with rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat Brain Res 1271 121 127 1:CAS:528:DC%2BD1MXltlejsb4%3D 10.1016/j.brainres.2009.03.040 19332033
3. FC Barone GZ Feuerstein 1999 Inflammatory mediators and stroke: new opportunities for novel therapeutics J Cereb Blood Flow Metab 19 819 834 1:CAS:528:DC%2BD3cXksFSktbk%3D 10.1097/00004647-199908000-00001 10458589 (Pubitemid 30173383)
4. M Bergeron AY Yu KE Solway GL Semenza FR Sharp 1999 Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain Eur J Neurosci 11 4159 4170 1:STN:280: DC%2BD3c%2Fmt1CrsA%3D%3D 10.1046/j.1460-9568.1999.00845.x 10594641 (Pubitemid 30009246)
5. A Bernardo G Levi L Minghetti 2000 Role of the and its natural ligand in the regulation of microglial functions Eur J Neurosci 12 2215 2223 1:STN:280:DC%2BD3cvjtlentw%3D%3D 10.1046/j.1460-9568.2000.00110.x 10947800 (Pubitemid 30497019)
6. F Biscetti E Gaetani A Flex T Aprahaimian T Hopkins G Straface G Pecorini E Stigliano RC Smith F Angelini JJ Castellot Jr R Pola 2008 Selective activation of peroxisome proliferator-activated receptor (PPAR)α and PPARγ induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism Diabetes 57 1394 1404 1:CAS:528:DC%2BD1cXlvVKjur4%3D 10.2337/db07-0765 18268046
7. F Biscetti G Straface V Arena E Stigliano G Pecorini P Rizzo G de Angelis L Iuliano G Ghirlanda A Flex 2009 Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARγ stimulation Cardiovasc Diabetol 8 49 10.1186/1475-2840-8-49 19737384
8. F Biscetti G Straface D Pitocco F Zaccardi G Ghirlanda A Flex 2009 Peroxisome proliferator-activated receptors and angiogenesis Nutr Metab Cardiovasc Dis 19 751 759 1:CAS:528:DC%2BC3cXhvFWqt7k%3D 10.1016/j.numecd.2009. 04.011 19628379
9. M Blanco MA Moro A Davalos R Leira M Castellanos J Serena J Vivancos 2005 Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke Stroke 36 1189 1194 1:CAS:528:DC%2BD2MXksVWrtLg%3D 10.1161/01.STR.0000166054.55993.e5 15879329 (Pubitemid 40798737)
10. V Bouët T Freret J Toutain D Divoux M Boulouard P Schumann-Bard 2007 Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse Exp Neurol 203 555 567 10.1016/j.expneurol.2006.09.006 17067578 (Pubitemid 46157224)
11. JK Callaway MJ Knight DJ Watkins PM Beart B Jarrott 1999 Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats Stroke 30 2704 2712 1:CAS:528:DyaK1MXotFWkt70%3D 10583001
12. E Candelario-Jalil A González-Falcón M García- Cabrera D Alvarez S Al-Dalain G Martínez OS León JE Springer 2003 Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia J Neurochem 86 545 555 1:CAS:528:DC%2BD3sXlvF2ntb8%3D 10.1046/j.1471-4159.2003.01812.x 12859668 (Pubitemid 36897435)
13. SD Chen HY Wu DI Yang SY Lee FZ Shaw TK Lin CW Liou YC Chuang 2006 Effects of rosiglitazone on global ischemia-induced hippocampal injury and expression of mitochondrial uncoupling protein 2 Biochem Biophys Res Commun 351 198 203 1:CAS:528:DC%2BD28XhtFequ77J 10.1016/j.bbrc.2006.10.017 17052689 (Pubitemid 44635426)
14. DW Choi 1992 Excitotoxic cell death J Neurobiol 23 1261 1276 1:CAS:528:DyaK3sXhtl2qtL4%3D 10.1002/neu.480230915 1361523
15. K Chu S-T Lee J-S Koo K-H Jung E-H Kim D-I Sinn J-M Kim S-Y Ko S-J Kim E-C Song M Kim J-K Roh 2006 Peroxisome proliferator-activated receptor-γ-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia Brain Res 1093 208 218 1:CAS:528:DC%2BD28Xms1ahsLw%3D 10.1016/j.brainres.2006.03.114 16696956 (Pubitemid 43946402)
16. RB Clark D Bishop-Bailey T Estrada-Hernandez T Hla L Puddington SJ Padula 2000 The nuclear receptor PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses J Immunol 164 1364 1371 1:CAS:528:DC%2BD3cXot1GrtA%3D%3D 10640751 (Pubitemid 30067250)
17. M Collino M Aragno R Mastrocola M Gallicchio AC Rosa C Dianzani O Danni C Thiemermann R Fantozzi 2006 Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion Eur J Pharmacol 530 70 80 1:CAS:528:DC%2BD28XhsFeqsw%3D%3D 10.1016/j.ejphar.2005.11.049 16386242 (Pubitemid 43037126)
18. L Cristiano A Bernardo M Ceru 2001 Peroxisome proliferator-activated receptors and peroxisomes in rat cortical and cerebellar astrocytes J Neurocytol 30 671 683 1:CAS:528:DC%2BD38XlsVyit7s%3D 10.1023/A:1016525716209 12118155 (Pubitemid 35007070)
19. L Cristiano A Cimini S Moreno AM Ragnelli M Ceru 2005 Peroxisome proliferator-activated receptors and related transcription factors in differentiating astrocyte cultures Neuroscience 131 577 587 1:CAS:528: DC%2BD2MXhslCgsLg%3D 10.1016/j.neuroscience.2004.11.008 15730864 (Pubitemid 40261214)
20. A Diab RZ Hussain AE Lovett-Racke JA Chavis PD Drew MK Racke 2004 Ligands for the peroxisome proliferator-activated receptor-γ and the retinoid receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis J Neuroimmunol 148 116 126 1:CAS:528:DC%2BD2cXht1yksb8%3D 10.1016/j.jneuroim.2003.11.010 14975592 (Pubitemid 38229564)
21. B Eklöf BK Siesjö 1972 The effect of bilateral carotid artery ligation upon the blood flow and the energy state of the rat brain Acta Physiol Scand 86 155 165 10.1111/j.1748-1716.1972.tb05322.x 4640167
22. M Fisher JH Garcia 1996 Evolving stroke and the ischemic penumbra Neurology 47 884 888 1:STN:280:DyaK2s%2FhtVKrsg%3D%3D 8857713 (Pubitemid 26362018)
23. K Fuenzalida R Quintanilla P Ramos D Piderit RA Fuentealba G Martinez NC Inestrosa M Bronfman 2007 Peroxisome proliferator-activated receptor Up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis J Biol Chem 282 37006 37015 1:CAS:528:DC%2BD2sXhsVamur3F 10.1074/jbc.M700447200 17965419
24. NT Gentile TK McIntosh 1993 Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury Ann Emerg Med 22 1028 1034 1:STN:280:DyaK3s3ns12ksA%3D%3D 10.1016/S0196-0644(05)82746-5 8099259 (Pubitemid 23163046)
25. SH Graham K Shiraishi SS Panter RP Simon AI Faden 1990 Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia Neurosci Lett 110 124 130 1:CAS:528:DyaK3cXktlygurY%3D 10.1016/0304-3940(90) 90799-F 1970140 (Pubitemid 20059565)
26. AL Hebb HA Robertson 2008 PDEs as drug targets for CNS immune disorders Curr Opin Investig Drugs 9 744 753 1:CAS:528:DC%2BD1cXpt1ajtb4%3D 18600580 (Pubitemid 351950871)
27. AJ Hunter J Hatcher D Virley P Nelson E Irving SJ Hadingham AA Parsons 2000 Functional assessments in mice and rats after focal stroke Neuropharmacol 39 806 816 1:CAS:528:DC%2BD3cXhsVWkt74%3D 10.1016/S0028-3908(99)00262-2 (Pubitemid 30103684)
28. E Kumura H Kosaka T Shiga T Yoshimine T Hayakawa 1994 Elevation of plasma nitric oxide end products during focal cerebral ischemia and reperfusion in the rat J Cereb Blood Flow Metab 14 487 491 1:CAS:528:DyaK2cXkvVSitLY%3D 8163591 (Pubitemid 24129483)
29. RE Law S Goetze XP Xi S Jackson Y Kawano L Demer MC Fishbein WP Meehan WA Hsueh 2000 Expression and function of PPARγ in rat and human vascular smooth muscle cells Circulation 101 1311 1318 1:CAS:528:DC%2BD3cXisVSqs7c%3D 10725292 (Pubitemid 30158620)
30. J Lee M Reding 2007 Effects of thiazolidinediones on stroke recovery: a case-matched controlled study Neurochem Res 32 635 638 1:CAS:528: DC%2BD2sXjtlynurw%3D 10.1007/s11064-006-9138-3 16960755 (Pubitemid 46481294)
31. S-R Lee H-Y Kim J-K Hong W-K Baek J-W Park 2009 PPARγ agonist pioglitazone reduces matrix metalloproteinase-9 activity and neuronal damage after focal cerebral ischemia Biochem Biophys Res Comm 380 17 21 1:CAS:528:DC%2BD1MXitVygsr4%3D 10.1016/j.bbrc.2008.12.181 19135426
32. P Lipton 1999 Ischemic cell death in brain neurons Physiol Rev 79 1431 1568 1:STN:280:DyaK1MvjvVagtw%3D%3D 10508238 (Pubitemid 29473320)
33. Y Luo W Yin AP Signore F Zhang Z Hong S Wang SH Graham J Chen 2006 Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone J Neurochem 97 435 448 1:CAS:528:DC%2BD28XksVykt7c%3D 10.1111/j.1471-4159.2006.03758.x 16539667
34. RB Maccioni LE Rojo JA Fernandez RO Kuljis 2009 The role of neuroimmunomodulation in Alzheimer's disease Ann N Y Acad Sci 1153 240 246 1:CAS:528:DC%2BD1MXjs1OntLo%3D 10.1111/j.1749-6632.2008.03972.x 19236346
35. R Marfella C Di Filippo M Portoghese M Siniscalchi S Martis F Ferraraccio S Guastafierro G Nicoletti M Barbieri A Coppola F Rossi G Paolisso M D'Amico 2009 The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control Cardiovasc Pathol 18 332 345 1:CAS:528:DC%2BD1MXhtlCnurbI 10.1016/j.carpath.2008.09.008 19144543
36. K Miki S Ishibashi L Sun H Xu W Ohashi T Kuroiwa H Mizusawa 2009 Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice J Neurosci Res 87 1270 1281 1:CAS:528:DC%2BD1MXjt12nsro%3D 10.1002/jnr.21925 18951530
37. MR Milot H Plamondon 2009 Time-dependent effects of global cerebral ischemia on anxiety, locomotion, and habituation in rats Behav Brain Res 200 173 180 10.1016/j.bbr.2009.01.009 19378462
38. I Modi JF MacDonald 1995 NMDA receptor-dependent excitotoxicity: the role of intracellular Ca+ release Trends Pharmacol Sci 16 356 359 10.1016/S0165-6147(00)89070-7
39. S Moreno S Farioli-Vecchioli MP Ceru 2004 Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS Neuroscience 123 131 145 1:CAS:528:DC%2BD3sXps1Ontb0%3D 10.1016/j.neuroscience.2003.08.064 14667448 (Pubitemid 37518482)
40. S Moyanova L Kortenska RG Mitreva VD Pashova RT Ngomba F Nicoletti 2007 Multimodal assessment of neuroprotection applied to the use of MK-801 in the endothelin-1 model of transient focal brain ischemia Brain Res 1153 58 67 1:CAS:528:DC%2BD2sXlvVyisLg%3D 10.1016/j.brainres.2007.03.070 17466282 (Pubitemid 46823888)
41. B Nieradko-Iwanicka A Borzecki 2008 Effect of cypermethrin on memory, movement activity and coordination in mice after transient incomplete cerebral ischemia Pharmacol Rep 60 699 705 1:CAS:528:DC%2BD1MXisFCgtLk%3D 19066417
42. H Ohtaki K Dohi T Nakamachi S Yofu S Endo Y Kudo S Shioda 2005 Evaluation of brain ischemia in mice Acta Histochem Cytochem 38 99 106 10.1267/ahc.38.99 (Pubitemid 40628423)
43. EE Olson RJ McKeon 2004 Characterization of cellular and neurological damage following unilateral hypoxia/ischemia J Neurol Sci 15 7 10 10.1016/j.jns.2004.07.021 (Pubitemid 39491120)
44. BC Park D Thapa JS Lee S-Y Park JA Kim 2009 Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells J Pharmacol Sci 111 1 12 1:CAS:528:DC%2BD1MXht1ert7vI 10.1254/jphs.08305FP 19763043
45. ED Rosen BM Spiegelman 2001 PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth J Biol Chem 276 37731 37734 1:CAS:528:DC%2BD3MXotFOrsbo%3D 10.1074/jbc.M106424200 11459852
46. ED Rosen P Sarraf AE Troy G Bradwin K Moore DS Milstone BM Spiegelman RM Mortensen 1999 PPAR γ is required for the differentiation of adipose tissue in vivo and in vitro Mol Cell 4 611 617 1:CAS:528:DyaK1MXntFCgsb4%3D 10.1016/S1097-2765(00)80211-7 10549292 (Pubitemid 29531140)
47. T Schallert SM Fleming JL Leasure JL Tillerson ST Bland 2000 CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, Parkinsonism and spinal cord injury Neuropharmacology 39 777 787 1:CAS:528:DC%2BD3cXhsVWktrY%3D 10.1016/S0028- 3908(00)00005-8 10699444 (Pubitemid 30103682)
48. Scoditti E, Massaro M, Carluccio MA, Distante A, Storelli C, de Caterina R (2010) PPARγ agonists inhibit angiogenesis by suppressing PKCα- and CREB-mediated COX-2 expression in the human endothelium. Cardiovasc Res. doi: 10.1093/cvr/cvp400
49. IM Shah IM Macrae M Di Napoli 2009 Neuroinflammation and neuroprotective strategies in acute ischaemic stroke-from bench to bedside Curr Mol Med 9 336 354 1:CAS:528:DC%2BD1MXktlant7k%3D 10.2174/156652409787847236
50. J Sharkey SP Butcher JS Kelly 1994 Endothelin-1 induced middle cerebral artery occlusion: pathological consequences and neuroprotective effects of MK801 J Autonom Nerv Sys 49 s177 s185 1:CAS:528:DyaK2cXmvFamtrs%3D 10.1016/0165-1838(94)90109-0
51. T Shimazu I Inoue N Araki Y Asano M Saeada D Furuya H Nagoya JH Greenberg 2005 A peroxisome proliferator-activated receptor-γ agonist reduces infarct size in transient but not in permanent ischemia Stroke 36 353 359 1:CAS:528:DC%2BD2MXmtVWhsg%3D%3D 10.1161/01.STR.0000152271.21943.a2 15618443 (Pubitemid 40170822)
52. PD Storer J Xu J Chavis PD Drew 2005 Peroxisome proliferator-activated receptor-γ agonists inhibit the activation of microglia and astrocytes: implications for the multiple sclerosis J Neuroimmunol 161 113 122 1:CAS:528:DC%2BD2MXhvVCjtbk%3D 10.1016/j.jneuroim.2004.12.015 15748950 (Pubitemid 40340879)
53. PJ Strijbos 1998 Nitric oxide in cerebral ischemic neurodegeneration and excitotoxicity Crit Rev Neurobiol 12 223 243 1:CAS:528:DyaK1cXnvVOntLk%3D 9847056 (Pubitemid 29002440)
54. JC Strum R Shehee D Virley J Richardson M Mattie P Selley S Ghosh C Nock A Saunders A Roses 2007 Rosiglitazone induces mitochondrial biogenesis in mouse brain J Alzheimers Dis 11 45 51 1:CAS:528:DC%2BD2sXisVGju70%3D 17361034 (Pubitemid 46376708)
55. H-S Sun TA Doucette Y Liu Y Fang L Teves M Aarts CL Ryan PB Bernard A Lau JP Forder MW Salter YT Wang RA Tasker M Tymianski 2008 Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat Stroke 39 2544 2553 1:CAS:528:DC%2BD1cXpvFGntbc%3D 10.1161/STROKEAHA.107.506048 18617669
56. S Sundararajan GE Landreth 2004 Antiinflammatory properties of PPARgamma agonists following ischemia Drug News Perspect 17 229 236 1:CAS:528: DC%2BD2cXmtlyitrY%3D 10.1358/dnp.2004.17.4.829049 15334171 (Pubitemid 38987364)
57. S Sundararajan JL Gamboa NA Victor EW Wanderi WD Lust GE Landreth 2005 Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarctions size in transient focal ischemia Neuroscience 130 685 696 1:CAS:528:DC%2BD2cXhtVKlsbbP 10.1016/j.neuroscience.2004.10.021 15590152 (Pubitemid 39601441)
58. C Szabo GJ Southan E Wood C Thiemermann JR Vane 1994 Inhibition by spermine of the induction of nitric oxide synthase in J774.2 macrophages: requirement of a serum factor Br J Pharmacol 112 355 356 1:CAS:528: DyaK2cXktleisbw%3D 7521253 (Pubitemid 24172868)
59. K Tanaka S Nogawa D Ito S Suzuki T Dembo A Kosakai Y Fukuuchi 2000 Activated phosphorylation of cyclic AMP response element binding protein is associated with preservation of striatal neurons after focal cerebral ischemia in the rat Neuroscience 100 345 354 1:CAS:528:DC%2BD3cXmslKmsbk%3D 10.1016/S0306-4522(00)00289-X 11008172
60. L Tian J Zhou MC Casimiro B Liang JO Ojeifo M Wang T Hyslop C Wang RG Pestell 2009 Activated peroxisome proliferator-activated receptor γ mutant promotes tumor growth in vivo by enhanced angiogenesis Cancer Res 69 9236 9244 1:CAS:528:DC%2BD1MXhsFGrtbvF 10.1158/0008-5472.CAN-09-2067 19934321
61. K Tureyen R Kapadia KK Bowen I Satriotomo J Liang DL Feinstein R Vemuganti 2007 Peroxisome proliferator-activated receptor-γ agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents J Neurochem 101 41 56 1:CAS:528:DC%2BD2sXksFSqsLk%3D 10.1111/j.1471-4159.2006.04376.x 17394460 (Pubitemid 46426485)
62. A Tuttolomondo D Di Raimondo R di Sciacca A Pinto G Licata 2008 Inflammatory cytokines in acute ischemic stroke Curr Pharm Dis 14 3574 3589 1:CAS:528:DC%2BD1MXptVCrsg%3D%3D 10.2174/138161208786848739
63. S Uryu J Harada M Hisamoto T Oda 2002 Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebllar granule neurons Brain Res 924 229 236 1:CAS:528:DC%2BD3MXpt1amurk%3D 10.1016/S0006-8993(01)03242-5 11750908 (Pubitemid 34102310)
64. A Vanella V Sorrenti C Castorina A Campisi C Di Giacomo A Russo JR Perez-Polo 1992 Lipid peroxidation in rat cerebral cortex during post-ischemic reperfusion: effect of exogenous antioxidants and Ca(++)-antagonist drugs Int J Dev Neurosci 10 75 80 1:CAS:528:DyaK38Xkt1Shsbw%3D 10.1016/0736-5748(92)90008-N 1609622
65. M Walton AM Woodgate E Sirimanne P Gluckman M Dragunow 1998 ATF-2 phosphorylation in apoptotic neuronal death Brain Res Mol Brain Res 63 198 204 1:CAS:528:DyaK1cXns1Ojsb0%3D 10.1016/S0169-328X(98)00275-7 9838112 (Pubitemid 28559102)
66. CX Wang X Ding R Noor C Pegg C He A Shauib 2009 Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats J Cereb Blood Flow Metab 29 1683 1694 1:CAS:528:DC%2BD1MXhtF2ltb7K 10.1038/jcbfm.2009.87 19553906
67. Wappler EA, Felszeghy K, Szilagyi G, Gal A, Skopal J, Mehra RD, Nyakas C, Nagy Z (2010) Neuroprotective effects of estrogen treatment on ischemia-induced behavioural deficits in ovariectomized gerbils at different ages. Behav Brain Res 209:42-48
68. DS Warner H Sheng I Batinić-Haberle 2004 Oxidants, antioxidants and the ischemic brain J Exp Biol 207 3221 3231 1:CAS:528:DC%2BD2cXovF2ku70%3D 10.1242/jeb.01022 15299043 (Pubitemid 39275296)
69. Xu J, Barger SW, Drew PD (2008). The PPAR-γ agonist 15-deoxy-Δ12,14-prostaglandin J2 attenuates microglial production of IL-12 family cytokines: potential relevance to Alzheimer's disease. PPAR Res. doi: 10.1155/2008/349185 (Pubitemid 352000623)
70. G Yang PH Chan SF Chen OA Babuna RP Simon PR Weinstein 1994 Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia Neursurgery 34 339 345 1:STN:280:DyaK2c3jt1Chuw%3D%3D 10.1227/00006123-199402000-00018 (Pubitemid 24044113)
71. X Zhao R Strong J Zhang G Sun JZ Tsien Z Cui JC Grotta J Aronowski 2009 Neuronal PPARγ deficiency increases susceptibility to brain damage after cerebral ischemia J Neurosci 29 6186 6195 1:CAS:528:DC%2BD1MXmt1Cmuro%3D 10.1523/JNEUROSCI.5857-08.2009 19439596